Bionova Scientific is a biologics-focused contract development and manufacturing organization (CDMO) that provides process development, analytical development, and GMP manufacturing services for recombinant protein therapeutics. Its capabilities span upstream and downstream development, mammalian cell culture–based production, single-use bioprocessing, technology transfer, and clinical supply.
Headquartered in Fremont, California, the company supports biopharmaceutical developers working on monoclonal antibodies and other complex protein biologics from early development through clinical stages. Bionova Scientific became part of the Asahi Kasei Group in 2022.
